DVA · XBRL financial data

Davita financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (DVA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	11,551	11,619	11,610	12,140	12,816	13,643
General and administrative	1,248	1,195	1,355	1,474	1,538	1,674
Operating income (loss)	1,695	1,797	1,339	1,603	2,090	2,044
Interest expense	283	267	339	374	435	540
Other income (expense)	17	6	(16)	(19)	(70)	(103)
Income tax expense (benefit)	314	307	198	220	280	293
Net income (loss)	774	978	560	692	936	747
Earnings per share, basic USD per share	6.46	9.30	6.03	7.62	11.02	10.06
Earnings per share, diluted USD per share	6.31	8.90	5.85	7.42	10.73	9.84
Weighted average shares, basic millions of shares	120	105	93	91	85	74
Weighted average shares, diluted millions of shares	123	110	96	93	87	76

Fiscal years (DVA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	325	462	244	380	795	676
Marketable securities	20	22	78	12	51	24
Marketable securities, non-current	32	50	44	48	34	41
Accounts receivable	1,824	1,958	2,132	1,987	2,147	2,415
Inventory	112	107	109	143	135	161
Prepaid and other current assets	76	73	79	103	123	156
Total current assets	3,149	3,168	3,155	3,138	3,746	4,058
Property and equipment, net	3,522	3,480	3,256	3,074	2,941	2,813
Right-of-use asset	2,863	2,825	2,666	2,501	2,394	2,397
Goodwill	6,919	7,046	7,077	7,113	7,375	7,545
Total assets	16,989	17,121	16,928	16,894	17,285	17,480
Accounts payable	434	402	480	515	547	696
Total current liabilities	2,476	2,399	2,620	2,642	2,973	3,142
Lease liability, non-current	2,739	2,673	2,503	2,330	2,210	2,176
Total liabilities	14,092	14,751	14,703	14,150	15,194	16,322
Retained earnings (accumulated deficit)	853	354	174	598	1,535	(328)
Total stockholders' equity	1,384	756	712	1,056	121	(651)
Total liabilities and equity	16,989	17,121	16,928	16,894	17,285	17,480
Common shares outstanding (cover page) millions of shares	109	≈96	≈90	≈88	≈80	≈67

≈ Rounded on cover: the filing states this count rounded, and it sits more than 1% off the weighted shares for the period.

Fiscal years (DVA's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	774	978	560	692	936	747
Stock-based compensation	91	102	95	112	103	140
Depreciation and amortization	617	668	721	736	716	708
Net cash from operating activities	1,979	1,931	1,565	2,059	2,022	1,887
Purchases of property and equipment	675	641	603	568	555	576
Net cash from investing activities	(825)	(785)	(630)	(772)	(771)	(655)
Share repurchases	1,458	1,539	802	272	1,386	1,308
Dividends paid	0	0	0	0	0	0
Proceeds from long-term debt	4,047	1,615	2,393	2,468	6,624	5,612
Net cash from financing activities	(1,847)	(1,083)	(1,121)	(1,170)	(817)	(1,375)
Net change in cash	(707)	53	(216)	126	415	(122)

SIC 8090 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 8090 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (8090) companies nearest in public float, each marked “added: same SIC”.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Davita	496	3,578	519*	62.9M	Q3 FY26 10-QSep 30, 2026
Concentra Group Holdings Parent	158	606	135*	127.5M	Q2 FY26 10-QJun 30, 2026
Progynyadded: same SIC	153	351	50*	76.7M	Q2 FY26 10-QJun 30, 2026
Sotera Healthadded: same SIC	412	325	111*	285.6M	Q3 FY26 10-QSep 30, 2026
agilon healthadded: same SIC	174	1,519	50*	16.8M	Q3 FY26 10-QSep 30, 2026
Viemed Healthcareadded: same SIC	9.7	81	11*	37.9M	Q3 FY26 10-QSep 30, 2026
Park Dental Partnersadded: same SIC	24	66	4.7*	4.8M	Q2 FY26 10-QJun 30, 2026
Quipt Home Medicaladded: same SIC	11	81	8.9	44.5M	Q1 FY26 10-QDec 31, 2025
Cryo Cell Internationaladded: same SIC	1.4	7.8	1.1*	8.1M	Q3 FY26 10-QAug 31, 2026

Not investment advice. Not affiliated with the U.S. SEC.